Nymox Pharmaceutical Has Held Its Pre-New Drug Application Chemistry Manufacturing And Controls Meeting With FDA Regarding Its Lead Product Candidate Fexapotide Triflutate, A Novel Prostate Injectable Developed For The Treatment Of Enlarged Prostate